Diagnostic Tools for Parkinson's Disease
Trial
N/A
Completed
Nov. 3, 2019
Local Field Potentials Recorded From Deep Brain Stimulating (DBS) Electrodes
Trial
N/A
Completed
Oct. 31, 2019
7T MRS in Parkinson's Disease
Trial
N/A
Completed
Oct. 31, 2019
Functional Connectivity Parkinson Disease
Trial
N/A
Completed
Oct. 31, 2019
Intravenous N-acetylcysteine for the Treatment of Gaucher's Disease and Parkinson's Disease
Trial
Phase 1
Completed
Oct. 31, 2019
Learning Effective New Strategies for Worry in Parkinson's Disease
Trial
N/A
Unknown
Oct. 30, 2019
Video Based Mindfulness Based Stress Reduction
Trial
N/A
Completed
Oct. 30, 2019
Trial of Probiotics for Constipation in Parkinson's Disease
Trial
N/A
Completed
Oct. 29, 2019
Helicobacter Pylori Eradication Study in Parkinson's Disease
Trial
N/A
Completed
Oct. 29, 2019
Transcranial Direct Current Stimulation (tDCS) and Parkinson's Disease
Trial
N/A
Completed
Oct. 29, 2019
Patient-Centered PD Ambulatory Monitoring System
Trial
N/A
Unknown
Oct. 28, 2019
A Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Trial
Phase 3
Completed
Oct. 28, 2019
Pharmacokinetics and Pharmacodynamics of IPX054 in Subjects With Parkinson's Disease
Trial
Phase 1
Completed
Oct. 28, 2019
Effect of L-Dihydroxyphenylserine (L-DOPS) on Falls in Patients With Neurogenic Orthostatic Hypotension (NOH)
Trial
Phase 2
Unknown
Oct. 28, 2019
Comparison of IPX054 and Immediate-Release Carbidopa-Levodopa in Patients With Parkinson's Disease
Trial
Phase 2
Completed
Oct. 28, 2019
A Study to Compare IPX066 and Carbidopa/Levodopa/Entacapone (CLE) Followed by an Open-Label Safety Study of IPX066
Trial
Phase 3
Completed
Oct. 28, 2019
Comparison of IPX054, IR Carbidopa-Levodopa, and CR Carbidopa-Levodopa in Subjects With Parkinson's Disease
Trial
Phase 2
Completed
Oct. 28, 2019
Influence of Trainning in Parkinson's Disease
Trial
N/A
Unknown
Oct. 22, 2019
SNS for Treatment of PD Gait Disorder
Trial
N/A
Unknown
Oct. 22, 2019
Bilateral Pallidal Stimulation in Patients With Advanced Parkinson's Disease-LATESTIM
Trial
N/A
Terminated
Oct. 21, 2019